Literature DB >> 11823256

Atypical antipsychotic medications and the treatment of schizophrenia.

David A Lewis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11823256     DOI： 10.1176/appi.ajp.159.2.177

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

Review 1.  Modern antipsychotic drugs: a critical overview.

Authors:  David M Gardner; Ross J Baldessarini; Paul Waraich
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

2.  Switch from risperidone to perospirone in patients with chronic schizophrenia.

Authors:  Kazuyuki Fujita; Toshihiko Fukuchi; Shoji Yuasa; Eriko Inada; Yoko Tarao; Kousuke Kanemoto
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

3.  Calcyon upregulation in adolescence impairs response inhibition and working memory in adulthood.

Authors:  A Vazdarjanova; K Bunting; N Muthusamy; C Bergson
Journal:  Mol Psychiatry       Date:  2011-03-15       Impact factor: 15.992

Review 4.  Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective.

Authors:  Mauro Percudani; Corrado Barbui; Michele Tansella
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.